Cem Zorlular

Cem Zorlular is CEO of Er-Kim, a specialty pharmaceutical company that serves as a regional affiliate to small and large pharma and biotech companies to commercialize their medicines in markets that fall outside of the U.S. and Western Europe.

Disruptive conditions are typical in non-Western markets. The U.S. industry, thrown into a period of significant change as the Trump administration overhauls HHS and considers implementing tariffs, could learn a thing or two by looking overseas.
There is a significant mismatch between the need for new antimicrobials and the traditional pharmaceutical business model.